Disparities in Monoclonal Antibody (mAb) Treatment Usage in the Military Health System During the COVID-19 Pandemic

Despite universal insurance, significant differences were observed in receipt of mAbs by race, rank (proxy for socioeconomic status), and sex. These results suggest that factors beyond insurance play roles in determining who receives mAbs. The provision of mAbs to non-high-risk patients also suggests a role for either patient- or provider-induced demand. Further research is needed to determine the scope of factors affecting mAb uptake in the MHS, and in other large health systems.